Japan health ministry panel recommends approval of Alzheimer's treatment Leqembi

Reuters -- Aug 22

A Japanese health ministry panel on Monday recommended approval of the Alzheimer's disease treatment Leqembi, following standard approval for the drug granted by U.S. regulators last month.

The expert panel's decision sets the stage for official approval of the drug, co-developed by Japan's Eisai (4523.T) and U.S.-based Biogen (BIIB.O).

...continue reading
Aug 22 () - 製薬会社大手「エーザイ」などが開発したアルツハイマー病の治療薬について、厚生労働省の専門部会は使用することを了承しました。承認されれば国内初の治療薬です。  ...continue reading